Skip to main content

stock

OTLK · Outlook Therapeutics, Inc.

What Outlook Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live OTLK price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on OTLK.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
243,447,554 as of 2026-08-14 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-233.4%

Health

Current ratio
0.8x
Debt/equity
—

Deep value

NCAV
-$13.41M
NCAV per share
-$0.06
Price/NCAV
Locked
NNWC
-$21.58M
NNWC per share
-$0.09
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30—-$8,265-$10.81M-$20.32M
10-Q filed 2026-08-18
2026-03-31—-$21,888-$14.03M-$4.45M
10-Q filed 2026-08-18
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—-$1.24M-$13.48M-$23.06M
10-Q filed 2026-08-18
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——-$17.31M-$13.29M
10-K filed 2025-12-19
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-06-30$1.51M$1.07M-$15.75M-$20.15M
10-Q filed 2026-08-18
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31——-$12.39M-$46.36M
10-Q filed 2026-08-18
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——-$21.61M$17.38M
10-Q filed 2026-08-18
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——-$22.88M$5.69M
10-K filed 2025-12-19
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assets
$26.18M
Equity
-$10.39M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-09-30$1.41M-$67.06M-$62.42M—
2024-09-30—-$71.70M-$75.37M—
2023-09-30—-$53.13M-$58.98M—
2022-09-30—-$63.07M-$66.05M—
2021-09-30—-$51.73M-$53.16M—
2020-09-30—-$36.84M-$35.24M—
2019-09-30$8.15M-$36.30M-$34.52M-$32.73M
2018-09-30$3.09M-$29.64M-$30.09M-$35.82M
2017-09-30$3.81M-$35.88M-$38.85M-$15.80M
2016-09-30$2.98M-$51.35M-$53.30M—

Company filings

since Fri Jul 17 · 8 offering filings in 12 months · since Fri Aug 14

events

  • Listing standard notice

    Listing standard notice
    Sep 308-K
  • Other event

    Other event
    Sep 188-K
  • Executive or director change

    Executive or director change
    Aug 278-K
  • Other event

    Other event
    Aug 148-K
  • Results

    Results
    Aug 148-K
  • Results, Other event

    ResultsOther event
    Aug 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Jahr Robert Charles

    Chief Executive Officer, Director

    Buyn/a

    Aug 14, 8:57 PM ET

  • Sukhtian Ghiath M.

    Director, 10% owner

    Buy$2,499,999

    Aug 14, 7:52 PM ET

  • KENYON LAWRENCE A

    Chief Financial Officer, Director

    Buyn/a

    Aug 14, 7:39 PM ET

  • Sukhtian Faisal Ghiath

    Director

    Buy$99,996

    Jul 29, 3:19 PM ET

All insider trades for OTLK

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named OTLK, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about OTLK.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about OTLK.

nakagai

Signals on OTLK come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the OTLK board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Outlook Therapeutics, Inc. (OTLK): SEC filings, financials and insider trades · Nakagai